By Preeyaporn Srasuebkul

Journal articles

Langton JM; Srasuebkul P; Buckley NA; Pearson S-A, 2013, 'Prescription Drug Use in the Last 12 Months of Life: Observations in a Cohort of Elderly Patients', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 22, pp. 352 - 352, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000334876101270&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Joshi V; Adelstein B-A; Srasuebkul P; Dobbins T; Pearson S-A, 2012, 'Estimating Disease Progression in Metastatic Cancer Patients Using Dispensing Data: A Validation Study', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 21, pp. 169 - 169, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308131701347&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lu CY; Srasuebkul P; Drew A; Ward RL; Pearson S, 2012, 'Positive spillover effects of prescribing requirements: Increased cardiac testing in patients treated with trastuzumab for HER2+ metastatic breast cancer', Internal Medicine Journal, 42, pp. 1229 - 1235, http://dx.doi.org/10.1111/j.1445-5994.2011.02604.x

Brown D; Hance KW; Rogers C; Sansbury ; Albert P; Murphy G; Laiyemo A; Wang Z; Cross A; Schatzkin A; Danta M; Srasu ; Amin J; Law MG; Breit SN; Lanza E; Brown , 2012, 'Serum Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15): A Potential Screening Tool for the Prevention of Colon Cancer?', Cancer Epidemiology Biomarkers and Prevention, 21, pp. 337 - 346, http://dx.doi.org/10.1158/1055-9965.EPI-11-0786

Puls R; Srasuebkul P; Petoumenos K; Boesecke C; Duncombe CJ; Belloso WH; Molina J; Li L; Avihingsanon A; Gazzard B; Cooper DA; Emery S, 2010, 'Efavirenz versus boosted atazanavir or zidovudine and abacavir in antirectroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study', Clinical Infectious Diseases, Oct 1; 51, pp. 855 - 864

Pujari S; Srasuebkul P; Sungkanuparph S; Lim PL; Kumarasamy N; Chuah J; Kumar R; Oka S; Choi J; Lee M; Phanuphak P; Kamarulzaman A; Lee C; Fujie Z; Ditangco R; Saphonn V; Sirisanthana T; Merati T; Law MG, 2009, 'Patient characteristics and treatment outcome associated with Protease Inhibitor (PI) use in the Asia-Pacific region', Journal of Antivirals & Antiretrovirals, 1, pp. 28 - 035, http://dx.doi.org/10.4172/jaa.1000004

Srasuebkul P; Lim PL; Lee M; Kumarasamy N; Zhou J; Sirisanthana T; Li P; Kamarulzaman A; Oka S; Phanuphak P; Vonthanak S; Merati T; Chen Y; Sungkanuparph S; Tau G; Zhang F; Lee CK; Ditangco R; Pujari S; Choi J; Smith J; Law MG, 2009, 'Short-term clinical disease progression in hiv-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV Observational database', Clinical Infectious Diseases, 48, pp. 940 - 950, http://dx.doi.org/10.1086/597354

Srasuebkul P; Sungkanuparph S; Lim P; Law MG, 2009, 'Universal Prophylaxis, Targeted Prophylaxis, and/or Preemptive Therapy for Opportunistic Infections at the Time of Initiation of Combination Antiretroviral Therapy for Patients with Advanced HIV Infection Reply', Clinical Infectious Diseases, 49, pp. 811 - U170

Pujari SN; Sungkanuparph S; Srasuebkul P; Lim PL; Kumarasamy N; Chuah J; Kumar RN; Phanuphak P, 2008, 'Patient characteristics and treatment outcomes associated with protease inhibitor (PI) use in the Asia-Pacific region', Journal of the International AIDS Society, 11, http://dx.doi.org/10.1186/1758-2652-11-s1-p72

Nuesch R; Ananworanich J; Srasuebkul P; Chetchotisakd P; Prasithsirikul W; Klinbuayam W; Mahanontharit A; Jupimai T; Ruxrungtham K; Hirschel B, 2008, 'Interruptions of tenofovir/emtricitabine based ART in patients with HIV/HBV co-infection', AIDS, 22, pp. 152 - 154

Nuesch R; Ananworanich J; Srasuebkul P; Chetchotisakd P; Prasithsirikul W; Klinbuayam W; Mahanontharit A; Jupimai T; Ruxrungtham K; Hirschel B, 2008, 'Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection', AIDS, 22, pp. 152 - 154

Srasuebkul P; Calmy A; Zhou J; Kumarasamy N; Law MG; Lim P, 2007, 'Impact of drug classes and treatment availability on the rate of antiretroviral treatment change in the TREAT Asia HIV Observational Database (TAHOD).', AIDS Research and Therapy, 4, pp. 18

Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG, 2007, 'Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment', HIV Medicine, 8, pp. 46 - 54

Huffam SE; Srasuebkul P; Zhou J; Calmy A; Saphonn V; Kaldor JM; Ditangco R, 2007, 'Prior antiretroviral therapy experience protects against zidovudine-related anaemia', HIV Medicine, 8, pp. 465 - 471

Boyd MA; Srasuebkul P; Khongphattanayothin M; Ruxrungtham K; Hassink EA; Duncombe CJ; Ubolyam S; Burger DM; Reiss P; Stek M; Lange JM; Cooper DA; Phanuphak P, 2006, 'Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005).', Antiviral Therapy, 11, pp. 223 - 232

Boyd MA; Carr AD; Ruxrungtham K; Srasuebkul P; Bien D; Law MG; Wangsuphachart S; Krisanachinda A; Lerdlum S; Lange J; Phanuphak P; Cooper DA; Reiss P, 2006, 'Changes in body composition and mitochondrial nucleic acid content in patients switched from failed nucleoside analogue therapy to Ritonavir-boosted Indinavir and Efavirenz', Journal of Infectious Diseases, 194, pp. 642 - 650

Nuesch R; Srasuebkul P; Ananworanich J; Ruxrungtham K; Phanuphak P; Duncombe CJ, 2006, 'Monitoring the toxicity of antiretroviral therapy in resource limited settings: a prospective clinical trial cohort in Thailand', Journal of Antimicrobial Chemotherapy, 58, pp. 637 - 644

Boyd MA; Srasuebkul P; Ruxrungtham K; Mackenzie P; Uchaipichat V; Stek M; Lange JM; Phanuphak P; Cooper DA; Udomuksorn W; Miners JO, 2006, 'Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir', Pharmacogenetics and Genomics, 16, pp. 321 - 329

Cardiello P; Hassink EA; Ananworanich J; Srasuebkul P; Samor TM; Mahanontharit A; Ruxrungtham K; Hirschel B; Lange JM; Phanuphak P; Cooper DA, 2005, 'A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection', Clinical Infectious Diseases, 40, pp. 594 - 600

Cardiello P; Srasuebkul P; Hassink EA; Mahanontharit A; Samor TM; Ruxrungtham K; Lange JM; Cooper DA; Phanuphak P, 2005, 'The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy', HIV Medicine, 6, pp. 122 - 128

Ungsedhapand C; Srasuebkul P; Cardiello P; Ruxrungtham K; Ratanasuwan W; Kroon E; Tongtalung M; Juengprasert N; Ubolyam S; Siangphoe U; Emery S; Lange JM; Cooper DA; Phanuphak P, 2004, 'Three-year durability of dual-nucleoside versus triple-nucleoside therapy in a Thai population with HIV infection', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 36, pp. 693 - 701

Ananworanich J; Nuesch R; Teeratakulpisarn S; Srasuebkul P; Chuenyam T; Siangphoe U; Ungsedhapand C; Phanuphak P; Ruxrungtham K, 2003, 'In vivo cell-mediated immunity in subjects with undetectable viral load on protease inhibitor-based versus non-protease inhibitor-based highly active antiretroviral therapy', Journal of Acquired Immune Deficiency Syndrome, 32, pp. 570 - 572

Pothikamjorn SL; Ruxrungtham K; Thampanitchawong P; Fuangthong R; Srasuebkul P; Sangahsapaviriyah A; Suttithavil W; Klaewsongkram J; Parisuthikul V; Viravan T; Rumsaeng V; Kana K; Direkwattanachai C; Kamchaisathien V; Phanupak P, 2002, 'Impact of particulate air pollutants on allergic diseases, allergic skin reactivity and lung function', Asia Pacific Journal of Allergy and Immunology, 20, pp. 77 - 83

Cardiello PG; van Heeswijk RP; Hassink EA; Srasuebkul P; Mahanontharit A; Samor TM; Worarien W; Beijnen JH; Hoetelmans RM; Ruxrungtham K; Cooper DA; Lange JM; Phanuphak P, 2002, 'Simplifying Protease Inhibitor Therapy with Once-Daily Dosing of Saquinavir Soft-Gelatin Capsules/Ritonavir (1600/100 mg): HIVNAT 001.3 Study', JAIDS Journal of Acquired Immune Deficiency Syndromes, 29, pp. 464 - 470, http://dx.doi.org/10.1097/00126334-200204150-00006

Cardiello P; van Heeswijk RP; Hassink EA; Srasuebkul P; Mahanontharit A; Samor TM; Worarien W; Beijnen JH; Hoetelmans RM; Ruxrungtham K; Cooper DA; Lange JM; Phanuphak P, 2002, 'Simplifying protease inhibitor therapy with once-daily dosing of saquinavir soft-gelatin capsules/ritonavir (1600/100mg):HIVNAT 001.3 study', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 29, pp. 464 - 470

Conference Papers

Gunaratne P; Srasuebkul P; Trollor J, 2022, 'MORTALITY AND CAUSE OF DEATH DURING INPATIENT PSYCHIATRIC CARE IN NEW SOUTH WALES, AUSTRALIA: A RETROSPECTIVE LINKED DATA STUDY', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, SAGE PUBLICATIONS LTD, pp. 192 - 193, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000792769900455&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Downs J; Jacoby P; Wong K; Srasuebkul P; Glasson E; Forbes D; Ravikumara M; Wilson A; Nagarajan L; Bourke J; Trollor J; Leonard H, 2019, 'HOSPITALISATIONS FOLLOWING GASTROSTOMY IN CHILDREN WITH INTELLECTUAL DISABILITY', in JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, WILEY, pp. 791 - 791, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000474486303067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Blanch B; Buckley NA; Srasuebkul P; Litchfield M; Pearson S-A, 2015, 'Prescribed opioid use and potential misuse in Australia (2006 to 2013)', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. 157 - 158, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000369980200273&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reeve R; Srasuebkul P; Pearson S; Viney R; Haas M, 2014, 'COSTS OF CANCER CARE AT THE END OF LIFE', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 39 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Srasuebkul P; Reeve R; Viney R; Haas M; Pearson S, 2014, 'RESOURCE USE IN THE LAST 180 DAYS OF LIFE IN THE ELDERLY DECENDENTS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 39 - +, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100107&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Harris CA; Pearson S; Daniels B; Srasuebkul P; Ward RL, 2013, 'HER2-positive early breast cancer (HER2EBC): An Australian pattern of care study', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Diego, presented at ASCO's Quality Care Symposium, CA, San Diego, 01 November 2013 - 02 November 2013, http://dx.doi.org/10.1200/jco.2013.31.31_suppl.101

Pearson S-A; Abrahamowicz M; Srasuebkul P; Buckley N, 2013, 'Antidepressant Treatment (ADT) Following a Cancer Diagnosis: Investigation in a Cohort of Older Patients', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. 199 - 199, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000334876100384&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pearson S-A; Srasuebkul P; Lu C; Dobbins T; Ward R, 2011, 'The Impact of Evidence-Based Subsidy Restrictions on Lapatinib Use and Outcomes', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. S77 - S77, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294946600172&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pearson S; Srasuebkul P; Harris C; Ward RL; Dobbins TA; Harris C, 2010, 'Trastuzumab treatment outcomes according to concomitant chemotheray regimen: Overall survival of HER2+ metastatic breast cancer patients', in Storm BL; Hasford J; Hennessy S; Park BJ (eds.), Pharmacoepidemiology and Drug Safety, John Wiley & Sons Ltd, Chichester, W Sussex, England, pp. S187 - S187, presented at Pharmacoepidemiology & Therapeutic Risk Management, Brighton, UK, 19 August 2010 - 22 August 2010, http://dx.doi.org/10.1002/pds

Puls RL; Srasuebkul P; Petoumenos K; Emery S; Cooper DA, 2009, 'Anthropometric and metabolic outcomes in a 48-week randomized, open-label study of three different combination antiretroviral regimens as initial therapy for HIV infection', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, PA, Philadelphia, pp. A8 - A9, presented at 11th International Workshop on AdverseDrug Reactions and Co-Morbidities in HIV, PA, Philadelphia, 26 October 2009 - 28 October 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000272060000026&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Presentations

joshi V; adelstein BA; Schaffer AL; srasuebkul P; EoCC Investigators ; dobbins T; pearson S, 2016, 'A Proxy of Cancer Progression in Dispensing Claims: Validation and Performance', presented at 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Montreal, Canada, 25 August 2016 - 28 August 2016, http://dx.doi.org/10.1002/pds.3512

Heintze T; Srasuebkul P; Trollor J, 2016, 'Too much of a good thing?: Exploring the meaning of statistical significance, population inference and omitted variable bias when using large administrative data samples', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383462000285&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Harris C; Pearson S-A; Daniels B; Srasuebkul P; Ward R, 2013, 'HER2 POSITIVE EARLY BREAST CANCER (HER2EBC): AN AUSTRALIAN PATTERN OF CARE STUDY', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lu CY; Srasuebkul P; Drew A; Chen K; Ward R; Pearson S-A, 2011, 'Cardiotoxic Cancer Therapies in Australia: Which Patients Are Assessed for Cardiac Function?', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294946600550&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts

Liao P; Reppermund S; Vajdic C; Trollor JN; Srasuebkul P, 2019, 'One-year readmission and Emergency department presentation after an epilepsy admission in people with intellectual disability: a registry-linkage study', in International Journal of Population Data Science, Swansea University, Vol. 4, http://dx.doi.org/10.23889/ijpds.v4i3.1269

Trollor J; Srasuebkul P; Reppermund S; Heintze T, 2019, 'TRANSLATING FINDINGS FROM POPULATION HEALTH DATA, QUALITATIVE RESEARCH AND POLICY ANALYSIS INTO CLINICAL BENEFIT FOR PEOPLE WITH INTELLECTUAL DISABILITY', in JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, WILEY, Vol. 63, pp. 681 - 681, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000474486301050&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cvejic RC; Srasuebkul P; Trollor JN, 2018, 'DOES ADMINISTRATIVE HEALTH DATA HAVE A PLACE IN BEHAVIOURAL PHENOTYPE RESEARCH?', in JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, WILEY, Vol. 62, pp. 666 - 667, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000438508800012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Trollor J; Srasuebkul P; Reeve R; Heintze T; Reppermund S, 2018, 'BUILDING CAPACITY IN INTELLECTUAL DISABILITY MENTAL HEALTH IN LOCAL HEALTH DISTRICTS: A COST-BENEFIT ANALYSIS', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, SAGE PUBLICATIONS LTD, Vol. 52, pp. 75 - 76, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000431625600182&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Li X; Trollor J; Reppermund S; Srasuebkul P, 2018, 'Emergency department presentation and readmission after index psychiatric admission: A data linkage study', in EUROPEAN PSYCHIATRY, ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, Vol. 48, pp. S447 - S447, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000461256106044&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Srasuebkul P; Trollor J; Florio T, 2016, 'Causes of death in adults with intellectual disabilities in the disability service system in New South Wales', in JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, WILEY-BLACKWELL, Vol. 60, pp. 739 - 739, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383462000585&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Srasuebkul P; Trollor J, 2016, 'Factors related to emergency department service use in people with intellectual disabilities in New South Wales', in JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, WILEY-BLACKWELL, Vol. 60, pp. 739 - 739, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383462000584&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hwang J; Srasuebkul P; Foley K-R; Florio T; Lennox N; Trollor J, 2016, 'Mortality and cause of death in those with intellectual disabilities with and without autism spectrum disorder: An exploration of New South Wales state-based administrative data', in JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, WILEY-BLACKWELL, Vol. 60, pp. 686 - 686, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383462000317&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Trollor J; Reeve R; Srasuebkul P, 2016, 'Utilisation and costs of hospital services for patients with intellectual disabilities', in JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, WILEY-BLACKWELL, Vol. 60, pp. 753 - 753, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383462000656&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reports

O'Shea P; Weise J; Purcal C; Fisher K; Srasuebkul P; Trollor J, 2024, Intellectual Disability and Mental Health Hubs Evaluation, http://dx.doi.org/10.26190/unsworks/30139

Back to profile page